372803
Poly(ethylene oxide)
average MV 2,000,000 (nominal), powder, hydroxyl, BHT as inhibitor
Synonym(s):
Polyethylene oxide, PEO
Sign Into View Organizational & Contract Pricing
All Photos(3)
About This Item
Linear Formula:
(-CH2CH2O-)n
CAS Number:
MDL number:
UNSPSC Code:
12352104
PubChem Substance ID:
NACRES:
NA.23
Recommended Products
product name
Poly(ethylene oxide), average Mv ~2,000,000 (nominal), powder
form
powder
Quality Level
mol wt
average Mv ~2,000,000 (nominal)
contains
200-500 ppm BHT as inhibitor
viscosity
2,000-4,000 cP, 2 % in H2O(25 °C, Brookfield)(lit.)
functional group
hydroxyl
SMILES string
[H]OCCO
InChI
1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2
InChI key
LYCAIKOWRPUZTN-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
Storage Class Code
11 - Combustible Solids
WGK
WGK 1
Flash Point(F)
281.5 °F - closed cup
Flash Point(C)
138.6 °C - closed cup
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
I L Konorova et al.
Patologicheskaia fiziologiia i eksperimental'naia terapiia, (4)(4), 7-9 (1991-07-01)
The search for antiaggregatory compounds is undertaken, as a rule, under in vitro conditions which do not reflect the dynamics of the real process. The present work deals with study of the peculiarities of the development of the collagen induced
P I Polimeni et al.
Journal of cardiovascular pharmacology, 14(3), 374-380 (1989-09-01)
The acute hemodynamic effects of an intravenously (i.v.) injected poly(ethylene oxide), Polyox WSR N-60K (dose 50 mg/kg), were studied in the open-chest rat anesthetized with sodium pentobarbital. The injectate is one of four drag-reducing polymers known to augment in vitro
D D Smyth et al.
Cardiovascular drugs and therapy, 4(1), 297-300 (1990-02-01)
Previous studies have demonstrated that Separan AP-30, a drag-reducing polymer, significantly decreased the formation of atherosclerotic plaques in rabbits fed a high-cholesterol diet. Furthermore, Separan AP-273, a polymer similar to but longer than Separan AP-30, markedly increased cardiac output in
M Patel Geeta et al.
Current drug delivery, 6(2), 159-165 (2009-05-20)
Carbamazepine indicated for the control of epilepsy, undergoes extensive hepatic first-pass metabolism after oral administration. A vaginal dosage form of carbamazepine is not commercially available. Conventional suppository having poor retention in the vaginal tract, as they are removed in a
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service